BioPharma
The biopharma industry offers big rewards – but it poses big risks, too. Rather than fearing the unknown, the concept of optionality can help you bet...
July 15, 2021 | Opinion | By Firman Ghouze, Cytiva, and Uriel Kusiatin, Provista Diagnostics Inc.
Robert Leasure, Jr., President and CEO of Inotiv, commented, “This transaction with MilliporeSigma adds genetic toxicology to our suite of internal c...
July 14, 2021 | News
Enzymatica has licensed to STADA exclusive rights to market and sell ViruProtect® (distributed by Enzymatica as ColdZyme®) in Vietnam. ...
July 14, 2021 | News
United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. ...
July 13, 2021 | News
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...
July 13, 2021 | News
Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that ad...
July 12, 2021 | News
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...
July 10, 2021 | News
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of a new bdbi...
July 08, 2021 | News
DYNAVAX AND BIOLOGICAL E ANNOUNCE COMMERCIAL SUPPLY AGREEMENT OF DYNAVAX’S CpG 1018 ADJUVANT FOR BIOLOGICAL E’S COVID-19 VACCINE CANDIDATE Dyn...
July 06, 2021 | News
The PIONEER IV trial is a prospective, random trial that will take place in 30 hospitals across Europe, enrolling 2,540 patients and involve patient...
July 05, 2021 | News
Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract...
July 01, 2021 | News
Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...
June 30, 2021 | News
Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate t...
June 30, 2021 | News
Evonik now offers ‘Chemistry in Water’, to enable classical organic reactions to be performed in water New technology allows drug manufactur...
June 30, 2021 | News
Most Read
Bio Jobs
News